Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Patients who have been treated in study protocol BAP089 may have responded to treatment, and
subsequently relapsed to >75% of the baseline disease severity, will be investigated for
response to further treatment with alitretinoin. Also, patients who have responded with mild
or moderate disease will be investigated for additional treatment effect after prolongated
treatment.